3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDSHemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndromeActive, not recruitingPhase 32026-09-11NCT03223961
Impact on Mortality of a Strategy Including Continuous Positive Airway Pressure Plus High Flow Nasal Cannula Oxygen Therapy Versus High Flow Nasal Cannula Oxygen Therapy Alone in Patients With de Novo Acute Hypoxemic Respiratory Failure: a Prospective, Randomized Controlled Trial.De Novo Hypoxemic Acute Respiratory Failure (hARF)RecruitingNot applicable2026-04-13NCT06213168
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular CarcinomaHepatocellular Carcinoma Recurrent; Liver Transplant; Systemic TreatmentRecruitingPhase 22026-03-10NCT06254248